Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Globe Biotech Limited is a leading biotechnology company based in Bangladesh and a subsidiary of the Globe Pharmaceuticals Group. The company focuses on the discovery and development of novel biologics, biosimilars, and vaccines to address unmet medical needs in the global market. Globe Biotech achieved significant recognition for developing Bongovax, the first mRNA-based COVID-19 vaccine candidate in Bangladesh. Its broader pipeline includes several biosimilar programs targeting oncology and autoimmune diseases, utilizing advanced molecular biology and fermentation technologies. The company operates a state-of-the-art research and manufacturing facility designed to produce high-quality biological drug substances at an affordable price.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Globe Laboratories.